BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions
PCI Significantly Expands Global Clinical Services Business Through Biotec Acquisition 9/19/2014
Allozyne, Inc. Sold For Scrap As MedImmune (AZN) Snaps Up Rights 9/19/2014
Cambridge Healthtech Institute & Knowledge Foundation Acquire The International Battery Seminar & Exhibition 9/18/2014
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company (LLY) For Development As A Personalized Medicine 9/17/2014
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL) 9/17/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buys Rights To Tildrakizumab From Merck & Co. (MRK) For An Upfront Payment Of $80 Million 9/17/2014
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants? 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal 9/17/2014
Google Inc. Dives Deeper Into Biotech With Lift Labs Acquisition 9/15/2014
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014
More Than 35% Of Allergan Inc. (AGN) Investors Demand Special Meeting; Support For Valeant Pharmaceuticals International (VRX) Merger Grows 9/12/2014
Sanofi (France) (SAN.PA) Aims For M&A With Genzyme Corporation (GENZ) 9/12/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
Mergers Hamper Innovation, Ex-Pfizer (PFE) Top Exec Says 9/11/2014
VWR International, LLC Expands European Tissue Diagnostics Portfolio With Acquisition Of Klinipath BV 9/10/2014
Kolltan Pharmaceuticals Inc. Acquires Xetrios Therapeutics And Exclusive Rights To Salk Institute for Biological Studies Patents Related To The TAM Receptor Tyrosine Kinase Family 9/10/2014
Mylan Inc. (MYL) Scoops Up Injectable Arixtra For $300 Million From Aspen Global Inc. 9/10/2014
Jazz Pharmaceuticals plc (JAZZ) Stock Up On Allergan Inc. (AGN) Rumor 9/9/2014
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires The Ownership Of Three Soft Gel ANDA's From Par Pharmaceutical, Inc. 9/9/2014
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Momenta Pharmaceuticals, Inc. (MNTA) Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc. 9/8/2014
Neos Therapeutics Acquires All Commercialization And Profit Rights To Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) From Chiesi USA And Coating Place, Inc. 9/8/2014
Envision Pharmaceutical Completes Its Acquisition Of Medtrak Services 9/8/2014
Medican Moves Toward Closing The Purchase Of 51 Percent Of International Herbs Medical Marijuana Ltd. (IHMML) 9/8/2014
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014
WellSpring Pharmaceutical Corporation Acquires BONINE®, An Over-The-Counter Drug For Motion Sickness, From Prestige Brands, Inc. 9/5/2014
DPT Laboratories, Ltd. Acquires Meda Pharmaceuticals’ Lakewood, New Jersey, Location 9/4/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
PPD, Inc. (PPDI) Acquires RCT Logic’s Exclusive License To Patented Clinical Trial Design Technology 9/3/2014
Albemarle Corporation (ALB) Completes Sale Of Antioxidant, Ibuprofen And Propofol Businesses To SI Group 9/3/2014
Eisai Inc. (ESALF.PK) Sells U.S. Rights To Zonegran® (zonisamide) Capsules To Concordia Pharmaceuticals 9/3/2014
MWI Veterinary Supply Acquires Vetspace 9/3/2014
Mercachem To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD) 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/28/2014
Tau Therapeutics, LLC And Xdynia Merge To Form Cavion 8/28/2014
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
Roper Industries Announces Two Medical Acquisitions 8/27/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
DPx Holdings B.V. Reaches Definitive Agreement To Acquire Gallus Biopharmaceuticals, LLC 8/27/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
VIVUS, Inc. (VVUS) Snags A Group Of Topiramate Patents From Johnson & Johnson (JNJ) 8/26/2014
Cannabis Science Inc. In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada 8/26/2014
Janssen Pharmaceutical Inc. Affiliate Cilag GmbH International Acquires Covagen AG 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Omnicell Closes Acquisition Of UK-Based Surgichem Limited And Updates 2014 Guidance 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Clinigen Group Further Strengthens Oncology Support Portfolio With Acquisition Of Ethyol® (Amifostine), From AstraZeneca PLC (AZN) 8/20/2014
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET® Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid 8/20/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE) 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Pharming Group (PHGUF.PK) Acquires New Product Leads Through The Acquisition Of Certain Assets Of TRM SASU For € 0.5 Million In Cash 8/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces Early Termination Of HSR Waiting Period For Pending Transaction 8/19/2014
GTCR Completes Acquisition Of Cole-Parmer Instrument Company 8/18/2014
Valeant Pharmaceuticals International (VRX) Extends Offer To Acquire Allergan Inc. (AGN) 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
SEC Investigating Valeant Pharmaceuticals International (VRX), Pershing Square's Hostile Takeover Bid For Allergan Inc. (AGN) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Allergan Inc. (AGN) Grabs TARIS Biomedical's Lead Program In Deal Worth $587.5 Million 8/14/2014
Mallinckrodt And Questcor Pharmaceuticals, Inc. (QCOR) Shareholders Approve Mallinckrodt's Acquisition Of Questcor 8/14/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
Valeant Pharmaceuticals International (VRX) Receives FTC Second Request Under Hart-Scott-Rodino 8/13/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014
Oncothyreon Inc. (ONTY) Announces Acquisition Of Alpine Biosciences 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
DRI Capital Pays Rush University Medical Center $42 Million For AMPYRA® Royalty Rights 8/12/2014
Allergan Inc. (AGN) Receives Second Request From Federal Trade Commission Regarding Valeant Pharmaceuticals International (VRX)’s Unsolicited Acquisition Proposal 8/11/2014
NextSourceCS Acquires Amatheon Compounding Services In An Effort To Help Alleviate The Absence Of Critical Discontinued Drugs In The Veterinary Industry 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Alvogen Pays $187 Million For Korea's Dream Pharma 8/6/2014
The Cooper Companies, Inc. (COO) Completes Acquisition Of Sauflon Pharmaceuticals Inc. And Announces $700 Million 3-Year Term Loan 8/6/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals 8/6/2014
Sterigenics International, Inc. Completes $826 Million Acquisition Of Nordion Inc. 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
CIRCADIAN® Acquires A Controlling Stake In ZircLight Inc. With A Series A Investment Led By Ams AG 8/5/2014
The HallStar Company Expands Organics Portfolio With Florasolvs® Natural Esters Acquisition 8/5/2014
Stem Cell Company ReproCELL (Japan) Acquires 3D Cell Culture Company Reinnervate Limited (UK) And Human Tissue Supplier Bioserve (USA) 8/5/2014
Merck & Co., Inc. (MRK) Completes Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 8/5/2014
Cellular Biomedicine Group (CBMG) Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent 8/4/2014
ANI Pharmaceuticals, Inc. Acquires Vancocin® Capsules And Additional Vancomycin Assets From Shire 8/4/2014
PCI Announces Completion Of Penn Pharmaceutical Services Purchase 8/4/2014
Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Vote FOR Mallinckrodt's Acquisition Of Questcor 8/4/2014
Nordion Receives Investment Canada Act Approval And Announces Expected Closing Date For Acquisition By Sterigenics 8/4/2014
Closing For Pernix Therapeutics, Inc. (PTX) Transaction To Acquire Treximet® Tablets For Migraine From GlaxoSmithKline (GSK) Delayed 8/4/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million 8/1/2014
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses 8/1/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Tigermed And Frontage Laboratories Complete Strategic Investment Agreement 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
Jin-En International Group Holding Co. Acquires Nascent Biotech Inc. And Changes Name To Nascent Biotech Inc. 7/29/2014
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX) 7/28/2014
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment 7/28/2014
PaxVax, Inc. Acquires FDA-Approved Typhoid Vaccine Vivotif 7/28/2014
Variation Biotechnologies Inc. And Paulson Capital Announce Completion Of Merger 7/28/2014
Rumor: Hospira, Inc. May Buy Danone's Medical-Nutrition Unit For $5 Billion 7/28/2014
PCI Expands Service Offering With Acquisition Of Penn Pharmaceutical Services 7/28/2014
Endo International plc (ENDP) Completes Acquisition Of Grupo Farmaceutico Somar® 7/25/2014
Simulations Plus (SLP) Provides Additional Details Regarding Cognigen Corporation Acquisition 7/25/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
WIRB-Copernicus Group Announces Acquisition Of Alliance Biosciences; Executives Join WCG Biosafety Division 7/24/2014
Simulations Plus (SLP) To Acquire Cognigen Corporation 7/24/2014
Chromatin, Inc. Acquires Sorghum Production And Supply Company, Production Seeds Plus, Inc. 7/23/2014
Waters Corporation (WAT) Acquires REIMS Technology, Strengthens Health Science Initiative 7/23/2014
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition 7/23/2014
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million 7/22/2014
Teva Pharmaceutical Industries Limited (TEVA) Completes Acquisition Of Labrys: Opens Door To A Strong And Novel Migraine Prevention And Treatment Franchise Within Its CNS Portfolio 7/21/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
ABL, Inc. Acquires Majority Interest In Platine Pharma Services 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/21/2014
Gentiva Health Services (GTIV) Grabs $634 Million Bid, Rejects Kindred Bio (KIN)'s Stake Offer 7/18/2014
Symplmed Completes Ownership Of Perindopril Franchise With Acquisition Of ACEON® 7/18/2014
Perrigo Co. (PRGO) Mum On Published Merger Rumors, Potential Target For Abbott Laboratories (ABT) 7/17/2014
Pfizer Inc. (PFE) Snags INNOPHARMA In $360 Million Deal 7/17/2014
Thermo Fisher Scientific (TMO) To Sell Cole-Parmer Instrument Company For $480 Million 7/17/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Investor Believes Roche (RHHBY) May Buy Exelixis, Inc. (EXEL) For Skin Cancer Drug 7/16/2014
Shire Ready To Bow To AbbVie (ABBV)'s Increased $53 Billion Offer 7/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly and Company (LLY) 7/15/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
EPIRUS Biopharmaceuticals And Zalicus Inc. (ZLCS) Complete Merger - Combined Company Will Trade As EPIRUS Biopharmaceuticals 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
Abbott Laboratories (ABT) Unloads Developed Markets Generics Unit To Mylan Inc. (MYL) For $5.3 Billion 7/14/2014
Ventrus Biosciences, Inc.  (VTUS) Becomes Assembly Biosciences As Stockholders Approve Merger With Assembly Pharmaceuticals 7/14/2014
ATS Labs, Inc. Announces the Acquisition Of MicroTest Labs, Inc. 7/14/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Lake Consumer Products Acquires License To Bring vH Essentials PMS Relief Product To Market 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Baxter International, Inc. (BAX) Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount 7/9/2014
NeoGenomics, Inc. (NGNM.OB) Completes Acquisition Of Path Logic 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Easton Pharmaceuticals (OP: EAPH) Announces Closing Of Agreement To Invest And Acquire Ownership Interest In AMFIL Technologies Inc. And The mPACT -GROzone Antimicrobial Systems Line Of Products 7/8/2014
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation  (SYK)'s BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
StoneCalibre Acquires Nucleic Acid Purification Products Manufacturer Edge BioSystems, Inc. 7/8/2014
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014
AbbVie (ABBV) To Dispatch Research Chief Jim Sullivan To London 7/7/2014
Merus Labs International Inc. Agrees To Buy Dacha Strategic Metals Inc. 7/7/2014
Hospira, Inc. Completes Acquisition Of Orchid Chemicals & Pharmaceuticals Ltd.'s Active Pharmaceutical Ingredient Manufacturing And R&D Facility 7/7/2014
Genentech (RHHBY) To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals 7/7/2014
IMPAX Laboratories, Inc. (IPXL) Acquires Two Products From Actavis (ACT) 7/3/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Bio-Techne Snags Novus Biologicals For $60 Million Cash 7/3/2014
PAREXEL International (PRXL) Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Integrated DNA Technologies Acquires SURVEYOR® Nuclease Business From Transgenomic, Inc. (TBIO) 7/2/2014
Quintiles, Inc. (Q) Completes Acquisition Of Encore Health Resources 7/2/2014
Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger 7/2/2014
Intrexon Corporation To Acquire Trans Ova Genetics 7/2/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
Massachusett's bluebird bio (BLUE) Snaps Up Pregenen For Up To $139.9 Million 7/2/2014
Bay Area's Transcept Pharmaceuticals, Inc. (TSPT) Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Transcept Stock Up +19.60% At Market Close (July 1, 2014) 7/1/2014
Johnson & Johnson (JNJ) Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 7/1/2014
Welichem Responds To Completion Of Take-Over Bid 7/1/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Forest 7/1/2014
Actavis (ACT) Completes Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014